LITE vs. TRVI

Last updated Jun 13, 2026

LITE (Lumentum Holdings Inc.) and TRVI (Trevi Therapeutics, Inc.) are both stocks. LITE operates in Communication Equipment (Technology), while TRVI operates in Biotechnology (Healthcare). Over the past 5 years, LITE returned 62.72%/yr vs 44.83%/yr for TRVI. At a 0.10 correlation, their price movements are largely independent.

Performance

LITE vs. TRVI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Lumentum Holdings Inc. (LITE) and Trevi Therapeutics, Inc. (TRVI). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, LITE achieves a 150.02% return, which is significantly higher than TRVI's 13.50% return.

LITE

• 1D: 3.59%
• 1M: -10.56%
• YTD: 150.02%
• 6M: 184.13%
• 1Y: 977.85%
• 3Y*: 158.28%
• 5Y*: 62.72%
• 10Y*: 43.74%

TRVI

• 1D: 5.57%
• 1M: -6.94%
• YTD: 13.50%
• 6M: 11.28%
• 1Y: 130.31%
• 3Y*: 75.70%
• 5Y*: 44.83%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

LITE vs. TRVI - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
LITE Lumentum Holdings Inc.	150.02%	339.06%	60.15%	0.48%	-50.68%	11.57%	19.55%	29.17%
TRVI Trevi Therapeutics, Inc.	13.50%	203.88%	207.46%	-30.57%	146.74%	-67.68%	-35.47%	-60.53%

Correlation

The correlation between LITE and TRVI is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.07
Correlation (3Y) Calculated over the trailing 3-year period	0.11
Correlation (5Y) Calculated over the trailing 5-year period	0.10
Correlation (All Time) Calculated using the full available price history since May 7, 2019	0.10

Fundamentals

EPS LITE : $5.26 TRVI : -$0.43
Total Revenue (TTM) LITE : $2.49B TRVI : $0.00
Gross Profit (TTM) LITE : $938.50M TRVI : -$31.00K
EBITDA (TTM) LITE : $470.10M TRVI : -$49.16M

Return for Risk

LITE vs. TRVI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LITE

LITE Risk / Return Rank: 99
LITE Sharpe Ratio Rank: 100
LITE Sortino Ratio Rank: 99
LITE Omega Ratio Rank: 98
LITE Calmar Ratio Rank: 100
LITE Martin Ratio Rank: 100

TRVI

TRVI Risk / Return Rank: 89
TRVI Sharpe Ratio Rank: 91
TRVI Sortino Ratio Rank: 87
TRVI Omega Ratio Rank: 86
TRVI Calmar Ratio Rank: 91
TRVI Martin Ratio Rank: 89

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LITE vs. TRVI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Lumentum Holdings Inc. (LITE) and Trevi Therapeutics, Inc. (TRVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	LITE	TRVI	Difference
Sharpe ratio: Return per unit of total volatility	11.43	2.17	+9.26
Sortino ratio: Return per unit of downside risk	5.42	2.72	+2.70
Omega ratio: Gain probability vs. loss probability	1.71	1.35	+0.36
Calmar ratio: Return relative to maximum drawdown	34.43	4.44	+29.98
Martin ratio: Return relative to average drawdown	126.26	10.40	+115.87

LITE vs. TRVI - Sharpe Ratio Comparison

The current LITE Sharpe Ratio is 11.43, which is higher than the TRVI Sharpe Ratio of 2.17. The chart below compares the historical Sharpe Ratios of LITE and TRVI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

LITE vs. TRVI - Drawdown Comparison

The maximum LITE drawdown since its inception was -66.89%, smaller than the maximum TRVI drawdown of -95.45%. Use the drawdown chart below to compare losses from any high point for LITE and TRVI.

Drawdown Indicators

	LITE	TRVI	Difference
Max Drawdown Largest peak-to-trough decline	-66.89%	-95.45%	+28.56%
Max Drawdown (1Y) Largest decline over 1 year	-28.70%	-29.50%	+0.80%
Max Drawdown (3Y) Largest decline over 3 years	-50.63%	-61.96%	+11.33%
Max Drawdown (5Y) Largest decline over 5 years	-66.48%	-80.26%	+13.78%
Max Drawdown (10Y) Largest decline over 10 years	-66.89%	—	—
Current Drawdown Current decline from peak	-12.49%	-7.73%	-4.76%
Average Drawdown Average peak-to-trough decline	-23.57%	-61.49%	+37.92%
Ulcer Index Depth and duration of drawdowns from previous peaks	7.81%	12.58%	-4.77%

Volatility

LITE vs. TRVI - Volatility Comparison

Lumentum Holdings Inc. (LITE) has a higher volatility of 28.12% compared to Trevi Therapeutics, Inc. (TRVI) at 13.78%. This indicates that LITE's price experiences larger fluctuations and is considered to be riskier than TRVI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LITE	TRVI	Difference
Volatility (1M) Calculated over the trailing 1-month period	28.12%	13.78%	+14.34%
Volatility (6M) Calculated over the trailing 6-month period	69.73%	39.38%	+30.35%
Volatility (1Y) Calculated over the trailing 1-year period	86.47%	60.39%	+26.08%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	59.94%	88.26%	-28.32%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	56.62%	99.35%	-42.73%

Dividends

LITE vs. TRVI - Dividend Comparison

Neither LITE nor TRVI has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both LITE and TRVI in my portfolio?

LITE and TRVI have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, LITE or TRVI?

LITE has higher volatility (28.12%) compared to TRVI (13.78%). In terms of maximum drawdown, LITE dropped -66.89% vs TRVI's -95.45%.

Which has better risk-adjusted returns?

LITE currently has the higher Sharpe Ratio (11.43 vs 2.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.